Response of patients with refractory myasthenia gravis to rituximab: a retrospective study

Rituximab in Autoimmune Hematologic Diseases: Not Just a Matter of B Cells

(2010) Roberto Stasi   SEMINARS IN HEMATOLOGY

Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy

(2009) Marinos C. Dalakas et al.   ANNALS OF NEUROLOGY

Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis

(2009) Thomas Dörner et al.   AUTOIMMUNITY REVIEWS

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

(2009) K. R. Carson et al.   BLOOD

Rituximab in non-haematological disorders of adults and its mode of action

(2009) Vickie McDonald et al.   BRITISH JOURNAL OF HAEMATOLOGY

CD20-depleting therapy in autoimmune diseases: from basic research to the clinic

(2009) F. Perosa et al.   JOURNAL OF INTERNAL MEDICINE

Rituximab for myasthenia gravis

(2009) Karl Stieglbauer et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Rituximab in the management of refractory myasthenia gravis

(2009) Nazlee Zebardast et al.   MUSCLE & NERVE

Successful treatment of refractory generalized myasthenia gravis with rituximab

(2008) C. Lebrun et al.   EUROPEAN JOURNAL OF NEUROLOGY

Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients

(2008) Isabel Illa et al.   JOURNAL OF NEUROIMMUNOLOGY

Invited Article: Inhibition of B cell functions: Implications for neurology

(2008) M. C. Dalakas   NEUROLOGY

Current and future standards in treatment of myasthenia gravis

(2008) Ralf Gold et al.   Neurotherapeutics

Steroids and immunosuppressant drugs in myasthenia gravis

(2008) Sivakumar Sathasivam   Nature clinical practice. Neurology